{
    "nctId": "NCT01310075",
    "briefTitle": "Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction",
    "officialTitle": "Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction: A Blinded, Prospective, Randomized, Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Number of Participants With Complications After Tissue Expander Replacement With Implant",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients undergoing immediate tissue expander reconstruction following mastectomy by any of the surgeon co-investigators are eligible for the study.\n2. Patients 18 years of age or older are eligible for the study.\n3. Patients undergoing skin-sparing mastectomy utilizing bioprosthetic mesh are eligible for the study.\n4. Patients who have not undergone autologous tissue breast reconstruction and intend to undergo implant only breast reconstruction.\n5. Patients who intend to remain under the MDACC surgeon's care until completion of the reconstruction.\n\nExclusion Criteria:\n\n1. Patients with prior radiation to the breast/chest wall of the ipsilateral breast .\n2. Patients who cannot be effectively reconstructed without the use of bioprosthetic mesh.\n3. Patients who are current smokers.\n4. Patients requiring additional intra-operative skin resections of greater than 1cm beyond the skin edge as a result of mastectomy flap devascularization.\n5. Patients who have a history of breast tissue expander or implant placement.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}